7001 - 7025 of 7916 Results
Title
Year
- Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s disease2014OPENTitle: Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson׳s diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1563Issue #:Start Page: 103End Page: 109Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2014.03.031Best OA location URL: https://europepmc.org/articles/pmc4146456?pdf=renderCitation Count: 16
-
OPENTitle: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 460Issue #: 1Start Page: 127End Page: 141Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20140334Best OA location URL: https://portlandpress.com/biochemj/article-pdf/460/1/127/678769/bj4600127.pdfCitation Count: 728
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo2014OPENTitle: Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivoJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 5Start Page: 1496End Page: 1513Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu057Best OA location URL: https://academic.oup.com/brain/article-pdf/137/5/1496/11140606/awu057.pdfCitation Count: 200
-
OPENTitle: Tremor retrainment as therapeutic strategy in psychogenic (functional) tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 647End Page: 650Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.029Best OA location URL: https://europepmc.org/articles/pmc4028378?pdf=renderCitation Count: 41
-
OPENTitle: EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese populationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 659End Page: 661Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.03.004Best OA location URL: https://europepmc.org/articles/pmc4034257?pdf=renderCitation Count: 15
-
OPENTitle: Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: A Retrospective AnalysisJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 29Issue #: 4Start Page: 425End Page: 431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00455-014-9522-0Best OA location URL: https://europepmc.org/articles/pmc4127154?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: Fox Trial Finder, un nouvel outil pour la recherche cliniqueJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 170Issue #:Start Page: A133End Page: A134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360Citation Count: 0
-
OPENTitle: Identifying blood-brain-barrier selective single-chain antibody fragmentsJournal Name: Biotechnology JournalPublisher: WileyVol: 9Issue #: 5Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/biot.201300550Best OA location URL: https://europepmc.org/articles/pmc4073886?pdf=renderCitation Count: 22
-
OPENTitle: Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-SynucleinJournal Name: Applied SciencesPublisher: MDPI AGVol: 4Issue #: 1Start Page: 66End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/app4010066Best OA location URL: https://www.mdpi.com/2076-3417/4/1/66/pdf?version=1395063831Citation Count: 52
- Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents2014OPENTitle: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 11Start Page: 2465End Page: 2480Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23583Best OA location URL: https://europepmc.org/articles/pmc4076169?pdf=renderCitation Count: 118
- Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of Principle2014OPENTitle: Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of PrincipleJournal Name: JMIR mhealth and uhealthPublisher: JMIR Publications Inc.Vol: 2Issue #: 1Start Page: e13End Page: e13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/mhealth.2799Best OA location URL: https://mhealth.jmir.org/2014/1/e13/PDFCitation Count: 84
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort2014OPENTitle: Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP CohortJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 184Issue #: 4Start Page: 966End Page: 975Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ajpath.2013.12.007Best OA location URL: http://ajp.amjpathol.org/article/S0002944014000121/pdfCitation Count: 125
-
OPENTitle: Association Studies of Sporadic Parkinson’s Disease in the Genomic EraJournal Name: Current GenomicsPublisher: Bentham Science Publishers Ltd.Vol: 15Issue #: 1Start Page: 2End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1389202914666131210212745Best OA location URL: https://europepmc.org/articles/pmc3958956?pdf=renderCitation Count: 24
- Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease2014RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 38
-
OPENTitle: Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 3Start Page: e91190End Page: e91190Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0091190Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0091190&type=printableCitation Count: 29
- Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's disease2014OPENTitle: Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 590End Page: 595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.022Best OA location URL: https://europepmc.org/articles/pmc4028404?pdf=renderCitation Count: 139
- Increased Precursor Cell Proliferation after Deep Brain Stimulation for Parkinson's Disease: A Human Study2014OPENTitle: Increased Precursor Cell Proliferation after Deep Brain Stimulation for Parkinson's Disease: A Human StudyJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 3Start Page: e88770End Page: e88770Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0088770Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088770&type=printableCitation Count: 49
- Parkinson disease-associated mutation R1441H in LRRK2 prolongs the “active state” of its GTPase domain2014OPENTitle: Parkinson disease-associated mutation R1441H in LRRK2 prolongs the “active state” of its GTPase domainJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 11Start Page: 4055End Page: 4060Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1323285111Best OA location URL: https://www.pnas.org/content/pnas/111/11/4055.full.pdfCitation Count: 105
-
RESTRICTEDTitle: Prodromal features for Parkinson's disease – baseline data from the TREND studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 21Issue #: 5Start Page: 766End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12382Citation Count: 104
- Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on ‘effective’ connectivity2014OPENTitle: Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on ‘effective’ connectivityJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 4Start Page: 1130End Page: 1144Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awu027Best OA location URL: https://academic.oup.com/brain/article-pdf/137/4/1130/13799493/awu027.pdfCitation Count: 207
-
OPENTitle: Concomitant pathologies among a spectrum of parkinsonian disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 5Start Page: 525End Page: 529Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.012Best OA location URL: https://europepmc.org/articles/pmc4028418?pdf=renderCitation Count: 126
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients2014OPENTitle: Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 3Start Page: 1340End Page: 1349Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci71640Best OA location URL: http://www.jci.org/articles/view/71640/files/pdfCitation Count: 219
-
RESTRICTEDTitle: The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid FormationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 136Issue #: 10Start Page: 3859End Page: 3868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/ja411577tCitation Count: 225
-
OPENTitle: The effect of deep brain stimulation randomized by site on balance in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 7Start Page: 949End Page: 953Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25831Best OA location URL: https://europepmc.org/articles/pmc4057940?pdf=renderCitation Count: 43
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials2014OPENTitle: Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trialsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 127Issue #: 6Start Page: 861End Page: 879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-014-1256-4Best OA location URL: https://europepmc.org/articles/pmc4034750?pdf=renderCitation Count: 211